Niki Parmar, a former Google AI researcher and co-author of the groundbreaking “Attention Is All You Need” paper, has joined ...

Vertex Pharmaceuticals Incorporated Investors: [email protected] Susie Lisa, CFA: +1 617-341-6108 or Miroslava Minkova: +1 617-341-6135 Media: [email protected] or International: +44 20 3204 ...

It's one of the top healthcare stocks in my portfolio. If I didn't already own this biotech stock, I wouldn't hesitate to buy ...

Super Micro Computer, Inc. (SMCI) stock is on an extended bull run and has more than doubled in 2025. The stock is now the ...

The ASX took a hit as Trump’s tariff threat rattled markets, while NAB's earnings miss saw its stock tank, adding to the unease.

The company also announced plans to proceed with a Phase 3 trial for suzetrigine, a decision that has left some analysts questioning the rationale. One commentator stated on X "Vertex often gets the ...

The company also announced plans to proceed with a Phase 3 trial for suzetrigine, a decision that has left some analysts questioning the rationale. One commentator stated on X "Vertex often gets the ...

Founded in 2017 and headquartered in Bengaluru, SpotDraft offers an AI-powered contract automation platform that assists ...

After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...

Conestoga Capital Advisors, an asset management company, released its fourth-quarter 2024 investor letter. A copy of the ...

With rising poll numbers and renewed purpose, the socialist Left Party's members are increasingly confident of maintaining representation in the Bundestag. It's a turnaround that few predicted.

To illustrate that point, let's discuss two stocks in the biotech industry that have moved in opposite directions so far this year: Vertex Pharmaceuticals ( VRTX -0.36%) and Moderna ( MRNA -1.93%).